tradingkey.logo

Shoulder Innovations Inc

SI
13.000USD
+0.260+2.04%
交易中 美东报价延迟15分钟
262.97M总市值
亏损市盈率 TTM

Shoulder Innovations Inc

13.000
+0.260+2.04%

关于 Shoulder Innovations Inc 公司

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

Shoulder Innovations Inc简介

公司代码SI
公司名称Shoulder Innovations Inc
上市日期Jul 31, 2025
CEOBall (Robert Joseph)
员工数量- -
证券类型Ordinary Share
年结日Jul 31
公司地址1535 Steele Avenue Sw, Suite B
城市GRAND RAPIDS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编49507
电话16165660286
网址https://shoulderinnovations.com/
公司代码SI
上市日期Jul 31, 2025
CEOBall (Robert Joseph)

Shoulder Innovations Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Matt Ahearn
Mr. Matt Ahearn
Chief Operating Officer, Director
Chief Operating Officer, Director
283.10K
+477.00%
Mr. David L. Blue
Mr. David L. Blue
Chief Customer Experience Officer
Chief Customer Experience Officer
183.31K
+1041.00%
Mr. Robert J. (Rob) Ball
Mr. Robert J. (Rob) Ball
Executive Chairman, Chief Executive Officer
Executive Chairman, Chief Executive Officer
175.53K
+8861.00%
Mr. Jeffrey S. Points
Mr. Jeffrey S. Points
Chief Financial Officer
Chief Financial Officer
55.52K
+3076.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
47.67K
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
20.06K
+13864.00%
Mr. Michael A. (Mike) Carusi
Mr. Michael A. (Mike) Carusi
Independent Director
Independent Director
--
-7666.00%
Mr. Geoff B. Pardo
Mr. Geoff B. Pardo
Independent Director
Independent Director
--
--
Mr. Kevin K. Sidow
Mr. Kevin K. Sidow
Independent Director
Independent Director
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Independent Director Nominee
Independent Director Nominee
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Matt Ahearn
Mr. Matt Ahearn
Chief Operating Officer, Director
Chief Operating Officer, Director
283.10K
+477.00%
Mr. David L. Blue
Mr. David L. Blue
Chief Customer Experience Officer
Chief Customer Experience Officer
183.31K
+1041.00%
Mr. Robert J. (Rob) Ball
Mr. Robert J. (Rob) Ball
Executive Chairman, Chief Executive Officer
Executive Chairman, Chief Executive Officer
175.53K
+8861.00%
Mr. Jeffrey S. Points
Mr. Jeffrey S. Points
Chief Financial Officer
Chief Financial Officer
55.52K
+3076.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
47.67K
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
20.06K
+13864.00%

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月7日 周六
更新时间: 2月7日 周六
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
18.57%
U.S. Venture Partners
13.07%
Gilde Healthcare Partners B.V.
11.55%
Lightstone Ventures, L.P.
9.15%
Cultivate(MD) Holdings LLC
6.62%
其他
41.03%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
18.57%
U.S. Venture Partners
13.07%
Gilde Healthcare Partners B.V.
11.55%
Lightstone Ventures, L.P.
9.15%
Cultivate(MD) Holdings LLC
6.62%
其他
41.03%
股东类型
持股股东
占比
Venture Capital
39.43%
Investment Advisor
23.33%
Hedge Fund
7.25%
Corporation
6.62%
Investment Advisor/Hedge Fund
5.09%
Individual Investor
3.97%
Research Firm
0.16%
Endowment Fund
0.07%
Bank and Trust
0.03%
其他
14.08%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
65
15.52M
56.18%
--
2025Q4
70
15.52M
75.34%
+3.47M
2025Q3
24
12.77M
62.72%
+9.43M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
3.83M
18.57%
-22.90K
-0.59%
Sep 30, 2025
U.S. Venture Partners
2.69M
13.07%
--
--
Sep 30, 2025
Gilde Healthcare Partners B.V.
2.38M
11.55%
+100.00K
+4.39%
Aug 01, 2025
Lightstone Ventures, L.P.
1.89M
9.15%
+266.67K
+16.48%
Sep 30, 2025
Cultivate(MD) Holdings LLC
1.36M
6.62%
-1.00
-0.00%
Sep 30, 2025
Arboretum Ventures, Inc.
1.16M
5.65%
+166.00K
+16.64%
Aug 01, 2025
Deerfield Management Company, L.P.
482.57K
2.34%
+482.57K
--
Sep 30, 2025
Alyeska Investment Group, L.P.
451.54K
2.19%
+451.54K
--
Sep 30, 2025
Sectoral Asset Management Inc.
430.28K
2.09%
+430.28K
--
Sep 30, 2025
Sio Capital Management, LLC
350.00K
1.7%
+350.00K
--
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
Global X Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI